VIEW HIGHLIGHTS FROM OUR GLOBAL CONFERENCE IN CHICAGO
Following the success of our 2016 Global eHealth Conference, Bioclinica is pleased to present our 2017 European eHealth Conference in London, England.
From the launch of the eHealth Cloud to the creation of our Financial Lifecycle and Safety and Regulatory Solutions Divisions, Bioclinica is creating a new technology-enabled approach that brings clarity to the drug development process.
Join us at London's historic Langham hotel where you will get VIP access to industry thought leaders and forward thinkers on how to achieve better outcomes in clinical trials—all with a focus on the patient.
Come share best practices and hear the latest innovations in expert panels, customer-led presentations and product demonstrations.
Tuesday, February 21st
Join us for a pre-event reception featuring a cooking competition hosted by celebrity chef Michel Roux
Wednesday, February 22nd
Following a full breakfast, we will start the day with a plenary session featuring innovations in clinical trial technology. After lunch, attendees will have their choice of sessions tracks focused on CTMS and Study Management, and Randomization and Trial Supply Management. The day will end with dinner at the exclusive Searcy's in London's famous Gherkin Tower.
Thursday, February 23rd
Day three kicks off with breakfast then three solution-oriented tracks focused on Cleaning Patient Data, Site Satisfaction, and Clinical Trial Risk and Cost Mitigation. Attendees will the join together in the general session room for a final round of plenary sessions devoted to lessons learned and future initiatives. Lunch will be served prior to departures.
Bioclinica is divided into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging and Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Biomarker Laboratory. Our eHealth segment comprises an eClinical Solutions Division along with Safety and Regulatory Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.